Market revenue in 2023 | USD 28.3 million |
Market revenue in 2030 | USD 46.5 million |
Growth rate | 7.4% (CAGR from 2023 to 2030) |
Largest segment | Bioavailability & bioequivalence studies |
Fastest growing segment | Bioavailability & Bioequivalence Studies |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Bioavailability & Bioequivalence Studies, Pharmacokinetics, Pharmacodynamics, Other test type |
Key market players worldwide | IQVIA Holdings Inc, Labcorp Holdings Inc, Thermo Fisher Scientific Inc, Pharmaron Beijing Co Ltd Ordinary Shares - Class H, Charles River Laboratories International Inc, Syneos Health, Intertek Group PLC |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cell & gene therapy bioanalytical testing services market will help companies and investors design strategic landscapes.
Bioavailability & bioequivalence studies was the largest segment with a revenue share of 35.34% in 2023. Horizon Databook has segmented the Latin America cell & gene therapy bioanalytical testing services market based on bioavailability & bioequivalence studies, pharmacokinetics, pharmacodynamics, other test type covering the revenue growth of each sub-segment from 2018 to 2030.
The increasing demand for pharmaceutical drugs is fueling the Latin America cell and gene therapy bioanalytical testing services market as pharmaceutical companies are investing in R&D. Furthermore, the presence of research training institutes in the region, the growing number of clinical trials, and the rising burden of diseases drive expansion in the Latin America market.
For instance, The Advanced Clinical Research Training Institute (CRTI) in Latin America provides continuous training and mentoring to graduates of the CRTI in the region. The training helps strengthen the clinical trial design and execution abilities gained from participation in the CRTI in Latin America. Moreover, it helps to gain a better knowledge of observational trial design and starts planning & carrying out one's observational research.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America cell & gene therapy bioanalytical testing services market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America cell & gene therapy bioanalytical testing services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account